AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (232 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Clinical neurorestorative progress in Parkinson’s disease

Lin Chen1,2( ), Hongyun Huang3,4,5, Wei-Ming Duan6( ), Gengsheng Mao3
Department of Neurosurgery, Yuquan Hospital, Tsinghua University,
Department of Neurosurgery, Medical Center, Tsinghua University,
Department of Neurosurgery, General Hospital of Chinese People’s Armed Police Forces,
Center of Cell Research, Beijing Rehabilitation Hospital of Capital Medical University,
Beijing Hongtianji Neuroscience Academy,
Department of Anatomy, Capital Medical University, Beijing, People’s Republic of China
Show Author Information

Abstract

Parkinson’s disease (PD) is one of the common neurodegenerative diseases. Besides the symptomatic therapies, the increasing numbers of neurorestorative therapies have shown the potential therapeutic value of reversing the neurodegenerative process and improving the patient’s quality of life. Currrently available novel clinical neurorestorative strategies include pharmacological managements (glial cell-line derived neurotrophic factor, selegiline, recombinant human erythropoietin), neuromodulation intervention (deep brain stimulation, repetitive transcranial magnetic stimulation, transcranial direct current stimulation), tissue and cell transplantation (fetal ventral mesencephalic tissue, sympathetic neurons, carotid body cells, bone marrow stromal cells, retinal pigment epithelium cells), gene therapy, and neurorehabilitative therapy. Herein, we briefly review the progress in this field and describe the neurorestorative mechanisms of the above-mentioned therapies for PD.

References

【1】
【1】
 
 
Journal of Neurorestoratology
Pages 101-107

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Chen L, Huang H, Duan W-M, et al. Clinical neurorestorative progress in Parkinson’s disease. Journal of Neurorestoratology, 2015, 3(1): 101-107. https://doi.org/10.2147/JN.S74144

1363

Views

56

Downloads

6

Crossref

6

Web of Science

0

Scopus

Published: 30 June 2015
© 2015 The Author(s).

© 2015 Chen et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php